Dinuclear asymmetric Zn aldol additions: Formal asymmetric synthesis of fostriecin

被引:115
作者
Trost, BM [1 ]
Frederiksen, MU [1 ]
Papillon, JPN [1 ]
Harrington, PE [1 ]
Shin, S [1 ]
Shireman, BT [1 ]
机构
[1] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
关键词
D O I
10.1021/ja042435i
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Direct asymmetric aldol reactions constitute a powerful methodology for the efficient synthesis of complex natural products. Herein we report the first application of our recently reported dinuclear Zn-catalyzed direct aldol addition of alkynyl ketones to aldehydes in a short and efficient formal asymmetric synthesis of fostriecin, a potent cyctotoxic natural product. This work highlights not only the power of the aldol methodology but also the utility of the akynyl silane aldol adducts, as it is subsequently utilized in a vinyl silane cross-coupling reaction which affords the target molecule in 14 steps for the longest linear sequence in 8.5% overall yield. Copyright © 2005 American Chemical Society.
引用
收藏
页码:3666 / 3667
页数:2
相关论文
共 36 条
[1]   Determination of the relative and absolute stereochemistry of fostriecin (CI-920) [J].
Boger, DL ;
Hikota, M ;
Lewis, BM .
JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (06) :1748-1753
[2]   Total synthesis of fostriecin (CI-920) [J].
Boger, DL ;
Ichikawa, S ;
Zhong, W .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (18) :4161-4167
[4]   Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition [J].
Buck, SB ;
Hardouin, C ;
Ichikawa, S ;
Soenen, DR ;
Gauss, CM ;
Hwang, I ;
Swingle, MR ;
Bonness, KM ;
Honkanen, RE ;
Boger, DL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (51) :15694-15695
[5]  
Chavez DE, 2001, ANGEW CHEM INT EDIT, V40, P3667, DOI 10.1002/1521-3773(20011001)40:19<3667::AID-ANIE3667>3.0.CO
[6]  
2-6
[7]   Synthesis of the C1-C12 fragment of fostriecin [J].
Cossy, J ;
Pradaux, F ;
BouzBouz, S .
ORGANIC LETTERS, 2001, 3 (14) :2233-2235
[8]  
CUSACK NJ, 1976, TETRAHEDRON, V32, P2157, DOI 10.1016/0040-4020(76)85128-9
[9]   Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin [J].
de Jong, RS ;
Mulder, NH ;
Uges, DRA ;
Sleijfer, DT ;
Höppener, FJP ;
Groen, HJM ;
Willemse, PHB ;
van der Graaf, WTA ;
de Vries, EGE .
BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) :882-887
[10]   Design and implementation of new, silicon-based, cross-coupling reactions: Importance of silicon-oxygen bonds [J].
Denmark, SE ;
Sweis, RF .
ACCOUNTS OF CHEMICAL RESEARCH, 2002, 35 (10) :835-846